---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-000112"
form_type: "8-K"
ticker: "BCRX"
cik: "0000882796"
company_name: "BIOCRYST PHARMACEUTICALS INC"
filed_at: "2025-01-08T23:59:59+00:00"
generated_at: "2026-05-28T07:26:36.471436+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# BioCryst raises ORLADEYO WAC 5% to $44,484.33 per 28-day pack effective Jan 8

## Summary
- ORLADEYO WAC raised from $42,366.03 to $44,484.33 per 28-day pack (150mg or 110mg).
- Price increase of approximately 5% effective January 8, 2025.
- The WAC increase applies to both the 150mg and 110mg capsule packs.

## SEC filing metadata
- accession: 0001171843-25-000112
- form_type: 8-K
- ticker: BCRX
- cik: 0000882796
- company_name: BIOCRYST PHARMACEUTICALS INC
- filed_at: 2025-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882796/000117184325000112/0001171843-25-000112-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882796/000117184325000112/f8k_010824.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-000112
- JSON: https://secwatch.observer/filing/0001171843-25-000112.json
- Plain text: https://secwatch.observer/filing/0001171843-25-000112.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.